Ara
Toplam kayıt 1, listelenen: 1-1
Zilovertamab vedotin (MK 2140) in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Early results from the phase 2 waveLINE-004 study.
(Lippincott Williams & Wilkins, 2023)
...
Toplam kayıt 1, listelenen: 1-1